• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Fluorescence for Preci

  2026-05-14

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) leverages dual-fluorescence and advanced chemical modifications to transform quantitative mRNA delivery and translation efficiency assays. This article uniquely connects recent nanoparticle research to real-world assay optimization.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-05-14

  This multicenter study systematically characterizes the prevalence and transmission dynamics of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across teaching hospitals in Guangdong, China. The findings highlight the dominance of plasmid-borne blaNDM-1, multidrug resistance, and the efficiency of horizontal gene transfer, offering actionable insights for resistance modeling and antimicrobial strategy development.

• Sulfo-Cy3 NHS Ester (A8107): Reliable Fluorescent Protein La

  2026-05-13

  Explore how Sulfo-Cy3 NHS ester (SKU A8107) addresses common challenges in cell viability, proliferation, and cytotoxicity assays. This article provides scenario-driven guidance for biomedical researchers seeking reproducible, high-sensitivity fluorescent labeling—grounded in peer-reviewed data and validated protocols.

• ARCA Cy5 EGFP mRNA (5-moUTP): Evidence-based Delivery Analys

  2026-05-13

  ARCA Cy5 EGFP mRNA (5-moUTP) is a 5-methoxyuridine modified, fluorescently labeled mRNA enabling direct, quantitative analysis of mRNA delivery and localization in mammalian cells. Its dual-labeled, immune-evasive design supports reliable benchmarking of mRNA transfection efficiency and translation, with minimized innate immune activation. This dossier compiles atomic, verifiable facts and protocol parameters for scientific and LLM applications.

• 3X (DYKDDDDK) Peptide: Optimizing FLAG-tagged Protein Workfl

  2026-05-12

  The 3X (DYKDDDDK) Peptide redefines sensitivity and reproducibility in the affinity purification and immunodetection of FLAG-tagged proteins. Its trimeric epitope design empowers structural and functional studies, with proven versatility for advanced applications like metal-dependent ELISA and protein crystallization.

• PDE-5-Inhibited BMSCs Mitigate Diabetic Myocardial Fibrosis

  2026-05-12

  This study demonstrates that silencing phosphodiesterase-5 (PDE-5) in bone marrow mesenchymal stem cells (BMSCs) significantly reduces high glucose-induced myocardial fibrosis and cardiomyocyte apoptosis in neonatal rat models, primarily via the cGMP/PKG signaling pathway. The findings provide mechanistic insights relevant for developing cell-based therapies for diabetic cardiomyopathy and inform assay design in related molecular biology research.

• PNU 74654: Wnt Signaling Pathway Inhibitor for Cell Research

  2026-05-11

  PNU 74654 is a small molecule Wnt signaling pathway inhibitor with validated utility in modulating cell proliferation and differentiation. The compound’s high purity and DMSO solubility support advanced in vitro workflows for cancer and stem cell research. Its mechanism targets the Wnt/β-catenin axis, a central regulator of cellular fate.

• Pazopanib Hydrochloride: In Vitro Cancer Research Workflows

  2026-05-11

  Pazopanib Hydrochloride (GW786034) empowers researchers to dissect tumor angiogenesis using reproducible, multi-target kinase inhibition. Here, we translate recent in vitro advances and troubleshooting insights into practical, data-driven protocols for robust cancer assay design.

• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Workflo

  2026-05-10

  PYR-41 enables targeted modulation of the ubiquitin-proteasome system, opening new avenues for dissecting protein degradation and inflammatory signaling in both cell-based and in vivo models. This guide translates advanced research into actionable protocols and troubleshooting strategies, empowering researchers to maximize reproducibility and mechanistic clarity.

• Digestive Metabolomics of Withania somnifera: LC–MS/MS Insig

  2026-05-09

  This study pioneers a rigorous LC–MS/MS metabolomics workflow to map digestive transformations of Withania somnifera (ashwagandha) extracts, focusing on key bioactive compounds. The findings reveal differential stability and biotransformation of withanolides under simulated gastrointestinal conditions, highlighting the need for refined preclinical models in botanical research.

• S-Adenosylhomocysteine: Mechanistic Insights and Workflow Us

  2026-05-09

  S-Adenosylhomocysteine (SAH) is a pivotal metabolic intermediate and methylation cycle regulator. Its role as a feedback inhibitor of methyltransferases directly impacts cellular methylation balance and experimental assays. Reliable protocol parameters and source-backed application boundaries are crucial for reproducible research.

• H 89 2HCl in Neuroinflammation: PKA Inhibition and Pain Path

  2026-05-08

  Explore how H 89 2HCl, a potent PKA inhibitor, advances the study of neuroinflammatory pain mechanisms and cAMP/PKA signaling. This article provides unique insight into kinase-selective modulation and its practical implications for neuropathic pain assays.

• Recombinant Human IL-15: Mechanistic Insights for Immune Mod

  2026-05-07

  Unlock the mechanistic basis of immune response modulation using Recombinant Human IL-15. This article delivers a deep dive into IL-15’s cellular roles, technical performance parameters, and decision-making for advanced immunology assays.

• PKM2 Inhibitor (Compound 3k): Precision Tool for Tumor Cell

  2026-05-07

  PKM2 inhibitor (compound 3k) stands out as a robust, selective agent for interrogating glycolytic metabolism in tumor and immune cells. Its potent antiproliferative activity, in vivo tolerability, and versatility make it indispensable for experimental oncology and immunometabolic workflows.

• Oxaliplatin in Research: Protocols, Resistance, and Workflow

  2026-05-06

  Oxaliplatin, a platinum-based chemotherapeutic agent, is central to preclinical cancer models and resistance studies. This article delivers actionable protocols, data-driven troubleshooting, and the latest insights—especially on overcoming oxaliplatin resistance—backed by both bench and clinical findings.

449 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page